Desrem 100,0 mg Lyophilized powder for Injection

Desrem 100,0 mg Lyophilized powder for Injection

S4
PDF Leaflet Revision Date: 03 October 2023

API: Remdesivir | Company: Mylan (Pty Ltd

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of COVID-19 in adults with pneumonia requiring supplemental oxygen.

Dosage (summary)

Day 1: 200 mg IV loading dose; Day 2+: 100 mg IV daily for 5-10 days.

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Not recommended in pregnancy; avoid breastfeeding during treatment.

Key Drug Interactions

  • Chloroquine
  • Hydroxychloroquine

Contraindications

  • Hypersensitivity to remdesivir or excipients

Common side effects

  • Nausea
  • Increased transaminases
  • Rash

Counselling Points

  • Monitor for hypersensitivity
  • Do not breast-feed
  • Use effective contraception

Serious warnings

  • Hypersensitivity reactions
  • Transaminase elevations
  • Renal toxicity
Important Disclaimer

The Desrem 100,0 mg Lyophilized powder for Injection professional information leaflet below is the property of Mylan (Pty Ltd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites